297 related articles for article (PubMed ID: 29362118)
1. Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management.
De Felice F; de Vincentiis M; Luzzi V; Magliulo G; Tombolini M; Ruoppolo G; Polimeni A
Oral Oncol; 2018 Feb; 77():125-130. PubMed ID: 29362118
[TBL] [Abstract][Full Text] [Related]
2. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.
Mazzola R; Ricchetti F; Fiorentino A; Fersino S; Giaj Levra N; Naccarato S; Sicignano G; Albanese S; Di Paola G; Alterio D; Ruggieri R; Alongi F
Br J Radiol; 2014 Dec; 87(1044):20140543. PubMed ID: 25348370
[TBL] [Abstract][Full Text] [Related]
3. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose to dysphagia aspiration-related structures and its effect on swallowing: Comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy plans.
Prameela CG; Ravind R; Renil Mon PS; Sheejamol VS; Dinesh M
J Cancer Res Ther; 2016; 12(2):845-51. PubMed ID: 27461662
[TBL] [Abstract][Full Text] [Related]
5. IMRT for head and neck cancer: reducing xerostomia and dysphagia.
Wang X; Eisbruch A
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i69-i75. PubMed ID: 27538846
[TBL] [Abstract][Full Text] [Related]
6. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
[TBL] [Abstract][Full Text] [Related]
7. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
8. Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.
Batth SS; Caudell JJ; Chen AM
Head Neck; 2014 Feb; 36(2):291-8. PubMed ID: 23508721
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
[TBL] [Abstract][Full Text] [Related]
10. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
[TBL] [Abstract][Full Text] [Related]
11. Functional swallowing outcomes related to radiation exposure to dysphagia and aspiration-related structures in patients with head and neck cancer undergoing definitive and postoperative intensity-modulated radiotherapy.
Charters E; Bogaardt H; Clark J; Milross C; Freeman-Sanderson A; Ballard K; Britton R; McCabe N; Davis H; Sullivan T; Wu R
Head Neck; 2022 Feb; 44(2):399-411. PubMed ID: 34808023
[TBL] [Abstract][Full Text] [Related]
12. Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.
Guillen-Sola A; Soler NB; Marco E; Pera-Cegarra O; Foro P
Trials; 2019 Aug; 20(1):503. PubMed ID: 31412947
[TBL] [Abstract][Full Text] [Related]
13. Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer.
Pauloski BR; Rademaker AW; Logemann JA; Discekici-Harris M; Mittal BB
Head Neck; 2015 Nov; 37(11):1575-82. PubMed ID: 24909649
[TBL] [Abstract][Full Text] [Related]
14. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer.
Anand AK; Chaudhoory AR; Shukla A; Negi PS; Sinha SN; Babu AA; Munjal RK; Dewan AK; Kumar K; Doval DC; Vaid AK
Br J Radiol; 2008 Nov; 81(971):865-71. PubMed ID: 18941046
[TBL] [Abstract][Full Text] [Related]
15. Oral complications of head and neck radiotherapy: prevalence and management.
Germano F; Melone P; Testi D; Arcuri L; Marmiroli L; Petrone A; Arcuri C
Minerva Stomatol; 2015 Aug; 64(4):189-202. PubMed ID: 25937580
[TBL] [Abstract][Full Text] [Related]
16. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
Martino R; Fitch MI; Fuller CD; Hope A; Krisciunas G; Langmore SE; Lazarus C; Macdonald CL; McCulloch T; Mills G; Palma DA; Pytynia K; Ringash J; Sultanem K; Theurer J; Thorpe KE; Hutcheson K
BMC Cancer; 2021 Oct; 21(1):1100. PubMed ID: 34645411
[TBL] [Abstract][Full Text] [Related]
17. Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.
Batham S; Gupta S; Ghosh A; Gupta IJ; Johny D; Srivastava S; Singh N; Bhatt M; Gupta R; Bhosale VV; Negi M
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3697-3704. PubMed ID: 38019227
[TBL] [Abstract][Full Text] [Related]
18. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.
Ursino S; D'Angelo E; Mazzola R; Merlotti A; Morganti R; Cristaudo A; Paiar F; Musio D; Alterio D; Bacigalupo A; Russi EG; Lohr F
Strahlenther Onkol; 2017 Nov; 193(11):877-889. PubMed ID: 28616822
[TBL] [Abstract][Full Text] [Related]
19. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
[TBL] [Abstract][Full Text] [Related]
20. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
